Familial Dysautonomia Differential Diagnoses
- Author: Robert A D'Amico; Chief Editor: Hampton Roy Sr, MD more...
Differential Diagnoses
- Alacrima
- Amblyopia
- Blepharitis, Adult
- Conjunctivitis, Bacterial
- Convergence Insufficiency
- Corneal Abrasion
- Corneal Erosion, Recurrent
- Corneal Mucous Plaques
- Dry Eye Syndrome
- Esotropia, Acquired
- Exotropia, Acquired
- Glaucoma, Aphakic And Pseudophakic
- Optic Neuropathy, Anterior Ischemic
- Sjogren Syndrome
- Sudden Visual Loss
- Ulcer, Corneal
Axelrod FB. Familial dysautonomia. Muscle Nerve. Mar 2004;29(3):352-63. [Medline].
Axelrod FB. A world without pain or tears. Clin Auton Res. Apr 2006;16(2):90-7. [Medline].
Riley CM, Day RL, Greeley DM. Central autonomic dysfunction with defective lacrimation: report of five cases. In: Pediatrics. Vol. 3. 1949:468-77.
Anderson SL, Coli R, Daly IW, et al. Familial dysautonomia is caused by mutations of the IKAP gene. Am J Hum Genet. Mar 2001;68(3):753-8. [Medline].
Leyne M, Mull J, Gill SP, et al. Identification of the first non-Jewish mutation in familial Dysautonomia. Am J Med Genet A. May 1 2003;118A(4):305-8. [Medline].
Slaugenhaupt SA, Blumenfeld A, Gill SP, et al. Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet. Mar 2001;68(3):598-605. [Medline].
Pearson J, Pytel BA, Grover-Johnson N, et al. Quantitative studies of dorsal root ganglia and neuropathologic observations on spinal cords in familial dysautonomia. J Neurol Sci. Jan 1978;35(1):77-92. [Medline].
Axelrod FB, Goldberg JD, Ye XY, et al. Survival in familial dysautonomia: Impact of early intervention. J Pediatr. Oct 2002;141(4):518-23. [Medline].
Brunt PW, McKusick VA. Familial dysautonomia. A report of genetic and clinical studies, with a review of the literature. Medicine (Baltimore). Sep 1970;49(5):343-74. [Medline].
Porges RF, Axelrod FB, Richards M. Pregnancy in familial dysautonomia. Am J Obstet Gynecol. Nov 1 1978;132(5):485-8. [Medline].
Elkayam L, Matalon A, Tseng CH, et al. Prevalence and severity of renal disease in familial dysautonomia. Am J Kidney Dis. Nov 2006;48(5):780-6. [Medline].
Clayson D, Welton W, Axelrod FB. Personality development and familial dysautonomia. Pediatrics. Feb 1980;65(2):269-74. [Medline].
Sands SA, Giarraffa P, Jacobson CM, et al. Familial dysautonomia's impact on quality of life in childhood, adolescence, and adulthood. Acta Paediatr. Apr 2006;95(4):457-62. [Medline].
Welton W, Clayson D, Axelrod FB, et al. Intellectual development and familial dysautonomia. Pediatrics. May 1979;63(5):708-12. [Medline].
Axelrod FB, Iyer K, Fish I, et al. Progressive sensory loss in familial dysautonomia. Pediatrics. Apr 1981;67(4):517-22. [Medline].
Blumenfeld A, Slaugenhaupt SA, Axelrod FB, et al. Localization of the gene for familial dysautonomia on chromosome 9 and definition of DNA markers for genetic diagnosis. Nat Genet. Jun 1993;4(2):160-4. [Medline].
Axelrod FB, Liebes L, Gold-Von Simson G, Mendoza S, Mull J, Leyne M, et al. Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia. Pediatr Res. Nov 2011;70(5):480-3. [Medline]. [Full Text].
Cohen-Kupiec R, Pasmanik-Chor M, Oron-Karni V, Weil M. Effects of IKAP/hELP1 deficiency on gene expression in differentiating neuroblastoma cells: implications for familial dysautonomia. PLoS One. Apr 29 2011;6(4):e19147. [Medline]. [Full Text].
Axelrod FB, Goldstein DS, Holmes C, et al. Pattern of plasma levels of catecholamines in familial dysautonomia. Clin Auton Res. Aug 1996;6(4):205-9. [Medline].
Axelrod FB, Goldberg JD, Rolnitzky L, et al. Fludrocortisone in patients with familial dysautonomia--assessing effect on clinical parameters and gene expression. Clin Auton Res. Aug 2005;15(4):284-91. [Medline].
Diamond GA, D'Amico RA, Axelrod FB. Optic nerve dysfunction in familial dysautonomia. Am J Ophthalmol. Dec 15 1987;104(6):645-8. [Medline].
Mendoza-Santiesteban CE, Hedges TR 3rd, Norcliffe-Kaufmann L, Warren F, Reddy S, Axelrod FB, et al. Clinical Neuro-ophthalmic Findings in Familial Dysautonomia. J Neuroophthalmol. Sep 13 2011;[Medline].
Bernardi L, Hilz M, Stemper B, et al. Respiratory and cerebrovascular responses to hypoxia and hypercapnia in familial dysautonomia. Am J Respir Crit Care Med. Jan 15 2003;167(2):141-9. [Medline].
Maayan C, Carley DW, Axelrod FB, et al. Respiratory system stability and abnormal carbon dioxide homeostasis. J Appl Physiol. Mar 1992;72(3):1186-93. [Medline].
Pflugfelder SC. Antiinflammatory therapy for dry eye. Am J Ophthalmol. Feb 2004;137(2):337-42. [Medline].
Anderson SL, Qiu J, Rubin BY. Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia. Biochem Biophys Res Commun. Jun 20 2003;306(1):303-9. [Medline].
Ilsar M, Hartstein ME, Maayan C. Punctal occlusion in patients with familial dysautonomia. Ann Ophthalmology. 1998;30(6):375-378.
Gungor I, Schor K, Rosenthal P, et al. The Boston Scleral Lens in the treatment of pediatric patients. J AAPOS. Jun 2008;12(3):263-7. [Medline].
Bonini S, Lambiase A, Rama P, et al. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology. Jul 2000;107(7):1347-51; discussion 1351-2. [Medline].
Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology. Jun 2004;111(6):1115-20. [Medline].
Chen HJ, Pires RT, Tseng SC. Amniotic membrane transplantation for severe neurotrophic corneal ulcers. Br J Ophthalmol. Aug 2000;84(8):826-33. [Medline]. [Full Text].
Tseng SC, Espana EM, Kawakita T, et al. How does amniotic membrane work?. Ocul Surf. Jul 2004;2(3):177-87. [Medline].
Ghinelli E. The Riley-Day syndrome. Arch Ophthalmol. Dec 1968;80(6):732-43.
Dohlman C, Waller S, Netland P. Keratoprosthesis Surgery. In: Lindquist T, Lindstrom R, eds. Ophthalmic Surgery. Vol L. 1996:1-32.
Ngai J, Kreynin I, Kim JT, et al. Anesthesia management of familial dysautonomia. Paediatr Anaesth. Jun 2006;16(6):611-20. [Medline].
AMX: Extract of human amniotic membrane. Presented at Italian Ocular Surface Society, Venice, Italy, June 2005.
Aragona P, Papa V, Micali A, et al. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol. Feb 2002;86(2):181-4. [Medline].
Axelrod FB. Familial dysautonomia. In: Burg FD, Ingelfinger JR, Polin RA, eds. Current Pediatric Therapy. 15th ed. Philadelphia, Pa: WB Saunders Co; 1996:91-94.
Axelrod FB. Familial dysautonomia: a review of the current pharmacological treatments. Expert Opin Pharmacother. Apr 2005;6(4):561-7. [Medline].
Cappellari M, Cavallaro T, Ferrarini M, Cabrini I, Taioli F, Ferrari S, et al. Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients. J Peripher Nerv Syst. Jun 2011;16(2):119-29. [Medline].
Kojima T, Ishida R, Dogru M, et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol. Feb 2005;139(2):242-6. [Medline].

